Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma. Cid-Bertomeu P, Huerva V. Surv Ophthalmol 2022 Mar 9. pii: S0039-6257(22)00039.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cid-Bertomeu P, Huerva V. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma. Surv Ophthalmol 2022 Mar 9. pii: S0039-6257(22)00039.
PMID: 35278438